Very small apolipoprotein A-I-containing particles from human plasma: Isolation and quantification by high-performance size-exclusion chromatography

Clinical Chemistry

Volumn 46, Issue 2, 2000, Pages 207-223

  Nanjee, M Nazeem ^a   Brinton, Eliot A ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; IMMUNOELECTROPHORESIS; LIPID ANALYSIS; LIPID METABOLISM; MALE; REPRODUCIBILITY; ULTRACENTRIFUGATION;

EID: 0033965266     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.2.207     Document Type: Article

References (98)

1. 1. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987;113:589-97.
2. 2. von Eckardstein A, Huang Y, Assmann G. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol 1994;5:404-16.
3. 3. Barter PJ, Rye K-A. High-density lipoproteins and coronary heart disease. Atherosclerosis 1996;121:1-12.
4. 4. Jones LA, Teramoto T, John DJ, Goldberg RB, Rubenstein AH, Getz GS. Characterization of lipoproteins produced by the perfused rhesus monkey liver. J Lipid Res 1984;25:319-35.
5. 5. Castle CK, Pape ME, Marotti KR, Melchior GW. Secretion of pre-β-migrating apo A-I by cynomolgus monkey hepatocytes in culture. J Lipid Res 1991;32:439-47.
6. 6. Cheung MC, Lum KD, Brouillette CG, Bisgaier CL. Characterization of apo A-I-containing lipoprotein subpopulations secreted by HepG2 cells. J Lipid Res 1989;30:1429-36.
7. 7. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry 1988;27:25-9.
8. 8. Fielding PE, Kawano M, Catapano A, Zoppo A, Marcovina S, Fielding CJ. Unique epitope of apolipoprotein A-I expressed in pre-β-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry 1994;33:6981-5.
9. 9. Oram JF, Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 1996;37:2473-91.
10. 10. Huang Y, von Eckardstein A, Assmann G. Cell-derived unesterified cholesterol cycles between different HDL and LDL for its effective esterification in plasma. Arterioscler Thromb 1993;13:445-8.
11. 11. Sviridov D, Fidge N. Pathway of cholesterol efflux from human hepatoma cells. Biochim Biophys Acta 1995;1256:210-20.
12. 12. Kawano M, Miida T, Fielding CJ, Relding PE. Quantitation of pre β-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry 1993;32: 5025-8.
13. 13. Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, et al. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry 1995;34:7955-65.
14. 14. Mendez AJ. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J Lipid Res 1997;38:1807-21.
15. 15. Yokoyama S. Apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta 1988;1392:1-15.
16. 16. Rothblat GH, Mahlberg FH, Johnson WJ, Phillips MC. Apolipoproteins, membrane cholesterol domains and the regulation of cholesterol efflux. J Lipid Res 1992;33:1091-7.
17. 17. Lefevre M, Sloop CH, Roheim PS. Characterization of dog prenodal peripheral lymph lipoproteins. Evidence for the peripheral formation of lipoprotein-unassociated apo A-I with slow pre-β electrophoretic mobility. J Lipid Res 1988:;29:1139-48.
18. 18. Smith EB, Ashall C, Walker JE. High-density-lipoprotein (HDL) subfractions in interstitial fluid from human aortic intima and atherosclerotic lesions. Biochem Soc Trans 1984;12:843-4.
19. 19. Heideman CL, Hoff HF. Lipoproteins containing apolipoprotein A-I extracted from human aortas. Biochim Biophys Acta 1982;711: 431-44.
20. 20. Nanjee MN, Miller NE. The very-high density lipoprotein fraction of rabbit plasma is rich in tissue-derived cholesterol. Biochim Biophys Acta 1991;1086:241-4.
21. 21. Miida T, Kawano M, Relding CJ, Fielding PE. Regulation of the concentration of pre β high-density lipoprotein in normal plasma by cell membranes and lecithin:cholesterol acyltransferase. Biochemistry 1992;31:12-7.
22. 22. Ishida BY, Albee D, Paigen B. Interconversion of preβ-migrating lipoproteins containing apolipoprotein A-I and HDL. J Lipid Res 1990;31:227-36.
23. 23. Neary R, Bhatnagar D, Durrington P, Ishola M, Arrol S, Mackness M. An investigation of the role of lecithin:cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-β high density lipoproteins. Atherosclerosis 1991;89:35-48.
24. 24. Liang H-Q, Rye K-A, Barter PJ. Remodeling of reconstituted high-density lipoproteins by lecithin:cholesterol acyltransferase. J Lipid Res 1996;37:1962-70.
25. 25. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995;36:211-28.
26. 26. Newnham HH, Barter PJ. Synergistic effects of lipid transfers and hepatic lipase in the formation of very small high-density lipoproteins during incubation of human plasma. Biochim Biophys Acta 1990;1044:57-64.
27. 27. von Eckardstein A, Jauhiainen M, Huang Y, Metso J, Langer C, Pussinen P, et al. Phospholipid transfer protein-mediated conver-sion of high-density lipoproteins (HDL) generates pre β1-HDL. Biochim Biophys Acta 1996;1301:255-62.
28. 28. Kunitake ST, Mendel CM, Hennessy LK. Interconversion between apolipoprotein A-I containing lipoproteins of pre-β and α electrophoretic mobilities. J Lipid Res 1992;33:1807-16.
29. 29. Jiang X-C, Francone OL, Bruce C, Milne R, Mar J, Walsh A, et al. Increased pre-β-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Investig 1996;96:2373-80.
30. 2: a study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem 1994;269:11572-7.
31. 31. Dugi KA, Vaisman BL, Sakai N, Knapper CL, Meyn SM, Brewer HB Jr, Santamarina-Fojo S. Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice. J Lipid Res 1997;38:1822-32.
32. 32. Nichols AV, Gong EL, Blanche PJ, Forte TM. HDL populations: origins and interconversions. In: Miller NE, ed. High density lipoproteins and atherosclerosis II. Amsterdam: Elsevier Science Publishers, 1989:159-71.
33. 33. Asztalos BF, Roheim PS. Presence and formation of "free apolipoprotein A-I-like" particles in human plasma. Arterioscler Thromb Vasc Biol 1995;15:1419-23.
34. 34. Glass CK, Pittman RC, Keller GA, Steinberg D. Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem 1983;258: 7161-7.
35. 35. Saku K, Reddy GS, Hynd BA, Kashyap ML. Renal handling of high-density lipoproteins by isolated perfused kidneys. Metabolism 1984;33:432-8.
36. 36. Peterson DR, Hjelle JT, Carone FA, Moore PA. Renal handling of plasma high-density lipoprotein. Kidney Int 1984;26:411-21.
37. 37. Nakai T, Whayne TF. Catabolism of canine apolipoprotein A-I, purification, catabolic rate, organs of catabolism and the liver subcellular catabolic site. J Lab Clin Med 1976;88:63-80.
38. 38. Goldberg IJ, Blaner WS, Vanni TM, Moukides M, Ramakrishnan R. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism: studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Investig 1990;86:463-73.
39. 39. Horowitz BS, Goldberg IJ, Merab J, Vanni TM, Ramakrishnan R, Ginsberg HN. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Investig 1993;91: 1743-52.
40. 40. Kashyap ML, Ooi BS, Hynd BA, Glueck CJ, Pollak VE, Robinson K. Sequestration and excretion of high density and low density lipoproteins by the kidney in human nephrotic syndrome. Artery 1979;6:108-21.
41. 41. Neary RH, Gowland E. The effect of renal failure and haemodialysis on the concentration of free apolipoprotein A-I in serum and the implications for the catabolism of high-density lipoproteins. Clin Chim Acta 1988;171:239-46.
42. 42. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, et al. Human apolipoprotein A-I and A-II metabolism. J Lipid Res 1982;23:850-62.
43. 43. Rader DJ, Castro G, Zech LA, Fruchart J, Brewer HB Jr. In vivo metabolism of apolipoprotein A-I on high-density lipoprotein particles LpA-I and LpA-I, A-II. J Lipid Res 1991;32:1849-59.
44. 44. Gylling H, Vega GL, Grundy SM. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high-density lipoprotein cholesterol in patients with normal plasma lipids. J Lipid Res 1992;33:1527-39.
45. 45. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apo A-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arterioscler Thromb Vasc Biol 1994;14:707-20.
46. 46. Ishida BY, Frolich J, Fielding CJ. Pre-β-migrating high-density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase RIA following electrophoretic transfer. J Lipid Res 1987;28:778-86.
47. 47. Francone OL, Fielding CJ, Fielding PE. Distribution of cell-derived cholesterol among plasma lipoproteins: a comparison of three techniques. J Lipid Res 1990;31:2195-200.
48. 48. O'Kane MJ, Wisdom GB, McEneny J, McFerran NV, Trimble ER. Pre-β high-density lipoprotein determined by immunoblotting with chemiluminescent detection. Clin Chem 1992;38:2273-7.
49. 49. Asztalos BF, Sloop CH, Wong L, Roheim PS. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I containing subpopulations. Biochim Biophys Acta 1993;1169: 291-300.
50. 50. Lefevre M, Goudey-Lefevre JC, Roheim PS. Gradient gel electrophoresis-immunoblot analysis (GGEI): a sensitive method for apolipoprotein profile determinations. J Lipid Res 1987;28:1495-7.
51. 51. Atmeh RF, Abuharfeil N. Electroblotting of proteins on agarose gel containing specific antibodies. Electrophoresis 1993;14:69-72.
52. 52. Atmeh RF, Robenek H. Measurement of small high-density lipoprotein subclass by an improved immunoblotting technique. J Lipid Res 1996;37:2461-9.
53. 53. Semprini A, Maddalena-Peruzzi A, Giunta S. Immunofixation electrophoresis (IFE) of serum apolipoproteins: a new tool for probing lipoprotein disorders and the atherosclerosis risk. Arch Gerontol Geriatr 1992;(Suppl 3):325-32.
54. 54. Giunta S, Maddalena-Peruzzi A, Gaudio MR, Semprini A. New in vitro findings on the "free" form of apolipoprotein A-I. Ann N Y Acad Sci 1992;673:342-9.
55. 55. Kunitake ST, La Sala KJ, Kane JP. Apolipoprotein A-I containing lipoproteins with pre-beta electrophoretic mobility. J Lipid Res 1985;26:549-55.
56. 56. Borresen A-L, Berg K. Presence of "free" apoA-I in serum: implications for immunological quantification of HDL and its apoproteins. Artery 1980;7:139-60.
57. 57. Gebhardt DOE, Schicht IM, Paul LC. The immunochemical determination of apolipoprotein A, total apolipoprotein A-I and "free" apolipoprotein A-I in serum of patients on chronic haemodialysis. Ann Clin Biochem 1984;21:301-5.
58. 58. Daerr WH, Minzlaff U, Greten H. Quantitative determination of apolipoprotein A-I in high-density lipoproteins and "free" apolipoprotein A-I by two-dimensional agarose gel lipoprotein - "rocket" immunoelectrophoresis of human serum. Biochim Biophys Acta 1986;879:134-9.
59. 59. Neary RH, Gowland E. Stability of free apolipoprotein A-I concentration in serum, and its measurement in normal and hyperlipidemic subjects. Clin Chem 1987;33:1163-9.
60. 60. Nowicka G, Bruning T, Bottcher A, Kahl G, Schmitz G. Macrophage interaction of HDL subclasses separated by free flow isotachophoresis. J Lipid Res 1990;31:1947-63.
61. 61. Duval F, Frommherz K, Atger V, Drueke T, Lacour B. Influence of end-stage renal failure on concentrations of free apolipoprotein A-I in serum. Clin Chem 1989;35:963-6.
62. 62. O'Connor PM, Naya-Vigne JM, Duchateau, Ishida BY, Mazur M, Schoenhaus SA, et al. Measurement of pre-β-1 HDL in human plasma by an ultrafiltration-isotope dilution technique. Anal Biochem 1997;251:234-40.
63. 63. Atmeh RF. Isolation and identification of HDL particles of low molecular weight. J Lipid Res 1990;31:1771-80.
64. 1-HDL and conversion into α-HDL: evidence for disturbed HDL conversion in Tangier disease. Arterioscler Thromb Vasc Biol 1995;15:1746-54.
65. 65. Miida T, Inano K, Nakamura Y, Matsuto T, Hoshiyama M, Kaneko K, Okada M. Abnormality of HDL subfractions in cholesteryl ester transfer protein deficiency. Jpn J Clin Pathol 1996;44:865-70.
66. 66. von Eckardstein A, Huang Y, Wu S, Funke H, Noseda G, Assmann G. Reverse cholesterol transport in plasmas of patients with different forms of familial high density lipoprotein deficiency. Arterioscler Thromb Vasc Biol 1995;15:691-703.
67. 1--high-density lipoprotein increases in coronary artery disease. Clin Chem 1996;42:1992-5.
68. 68. Sasahara T, Yamashita T, Sviridov D, Fidge N, Nestel P. Altered properties of high-density lipoprotein subfractions in obese subjects. J Lipid Res 1997; 38:600-11.
69. 69. O'Connor PM, Zysow BR, Schoenhaus SA, Ishida BY, Kunitake ST, Naya-Vigne JM, et al. Pre-β-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender. J Lipid Res 1998;39:670-8.
70. 70. Asztalos BF, Lefevre M, Foster TA, Tulley R, Windhauser M, Wong L, Roheim PS. Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations. Arterioscler Thromb Vasc Biol 1997;17:1885-93.
71. 71. Lipid Research Clinics Program. Manual of laboratory operations, Vol 1. Lipid and lipoprotein analysis. DHEW Publication No. (NIH) 75-628. Washington, DC: US Government Printing Office, May 1974.
72. 72. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
73. 73. Nanjee MN, Crouse JR, King JM, Hovorka R, Rees SE, Carson ER, et al. Effects of intravenous infusion of lipid-free apo A-I in humans. Arterioscler Thromb Vasc Biol 1996;16:1203-14.
74. 74. Nanjee MN, Miller NE. Sequential microenzymatic assay of cholesterol, triglycerides and phospholipids in a single aliquot. Clin Chem 1996;42:915-26.
75. 75. Kelley JL, Kruski AW. Density gradient ultracentrifugation of serum lipoproteins in a swinging bucket rotor. Methods Enzymol 1986; 128:170-81.
76. 76. Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 1996;16: 431-40.
77. 77. Schonfeld G, Bailey A, Steelman R. Plasma apo A-I and A-II in hyperlipidemia. Lipids 1978;13:951-9.
78. 78. Vezina CA, Milne RW, Weech PK, Marcel YL. Apolipoprotein distribution in human lipoproteins separated by polyacrylamide gradient gel electrophoresis. J Lipid Res 1988;29:573-85.
79. 79. Hennessy LK, Kunitake ST, Kane JP. Apolipoprotein A-I containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-β high-density lipoprotein particles. Biochemistry 1993;32: 5759-65.
80. 80. Reichl D, Forte TM, Hong J-L, Rudra DN, Pflug JJ. Human lymphedema fluid lipoproteins: particle size, cholesterol and apolipoprotein distributions, and electron microscopic structure. J Lipid Res 1985;26:1399-411.
81. 81. Melchior GW, Castle CK. Apolipoprotein A-I metabolism in cynomolgus monkey: identification and characterization of β-migrating pools. Arteriosclerosis 1989;9:470-8.
82. 82. Carroll RM, Rudel LL. Lipoprotein separation and low-density lipoprotein molecular weight determination using high performance gel-filtration chromatography. J Lipid Res 1983;24:200-7.
83. 4. Endocrinology 1989;124:1265-9.
84. 84. Marques-Vidal P, Jauhiainen M, Metso J, Ehnholm C. Transformation of high-density lipoprotein 2 particles by hepatic lipase and phospholipid transfer protein. Atherosclerosis 1197;133:87-95.
85. 85. Duverger N, Rader D, Brewer HB Jr. Distribution of subclasses of HDL containing apo A-I without apo A-II (LpA-I) in normolipidemic men and women. Arterioscler Thromb 1994;14:1594-9.
86. 86. Liang H-Q, Rye K-A, Barter PJ. Dissociation of lipid-free apolipoprotein A-I from high-density lipoproteins. J Lipid Res 1994;35:1187-99.
87. 1 migrating particles and decreases LCAT activation. Atherosclerosis 1998; 139:351-62.
88. 1 high-density lipoprotein from human ovarian follicular fluid: evidence for the presence of a lipid core. Biochemistry 1996;35:1352-7.
89. 89. Osborne JC Jr, Brewer HB Jr. Solution properties of the plasma apolipoproteins. Ann N Y Acad Sci 1980;348:104-21.
90. 90. von Eckardstein A, Chirazi A, Schuler-Luttman S, Walter M, Kastelein JJ, Geisel J, et al. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. J Lipid Res 1998;39:987-97.
91. 91. Schreyer SA, Hart LK, Attie AD. Hypercatabolism of lipoprotein-free apolipoprotein A-I in HDL-deficient mutant chickens. Arterioscler Thromb Vasc Biol 1994;14:2053-9.
92. 92. Ha YC, Trifunovic Z, Tajima S, Ishikawa K, Yamamoto A, Tarui S. Human apolipoprotein A-I forms small high-density lipoprotein particles in rats in vivo. Biochim Biophys Acta 1992;1125:223-9.
93. 93. Kubo M, Matsuzawa Y, Tajima S, Ishikawa K, Yamamoto A, Tarui S. Apo A-I and apo A-II inhibit hepatic triglyceride lipase from human postheparin plasma. Biochim Biophys Res Commun 1981; 100:261-6.
94. 94. Shinomiya M, Sasaki N, Barnhart RI, Shirai K, Jackson RL. Effect of apolipoproteins on the hepatic lipase-catalyzed hydrolysis of human plasma high-density lipoprotein2-triacylglycerols. Biochim Biophys Acta 1982;713:292-9.
95. 95. Jahn CE, Osborne JC Jr, Schaefer EJ, Brewer HB Jr. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II: characterization of a major component of high-density lipoprotein as the activating plasma component in vitro. Eur J Biochem 1983;131:25-9.
96. 96. Miida T, Inano K, Yamaguchi T, Tsuda T, Okada M. LpA-I levels do not reflect pre β1-HDL levels in human plasma. Atherosclerosis 1997;133:221-6.
97. 97. Kunitake ST, Kane JP. Factors affecting the integrity of high-density lipoprotein in the ultracentrifuge. J Lipid Res 1982;23: 936-40.
98. 98. Cheung MC, Wolf AC. Differential effect of ultracentrifugation on apolipoprotein A-I-containing lipoprotein subfractions. J Lipid Res 1988;29:15-25.